image: Oncotarget's Volume 13 view more
Credit: Impact Journals
BUFFALO, NY- June 23, 2022 – At the start of 2022, Oncotarget began publishing research papers in a continuous publishing format in yearly volumes. As of June 23, 2022, Oncotarget has published a total of 64 high-impact, oncology-focused papers within Volume 13. Oncotarget’s Volume 13 consists of papers authored by numerous prestigious researchers and scientists from world-renowned institutions. Select papers in this Volume were chosen for inclusion in Oncotarget’s Special Collections on breast and lung cancer research.
You can click the links below to learn more about the groundbreaking research papers and perspectives, meeting and case reports, commentaries, editorials, and reviews published by Oncotarget in 2022. You may also visit the Oncotarget YouTube channel to watch video previews of papers published by Oncotarget.
1. Research Paper: Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models
Authors: Lindsay R. Stolzenburg, Barrett Ainsworth, Bridget Riley-Gillis, Tibor Pakozdi, Areej Ammar, Paul A. Ellis, Julie L. Wilsbacher, and Cyril Y. Ramathal
2. Editorial: Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench
Authors: Vivek Subbiah and Razelle Kurzrock
3. Commentary: Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away
Author: Len Neckers
4. Research Perspective: The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
Authors: Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Julien Taieb, Mehdi Karoui, Petra Custers, Edina Dizdarevic, Soledad Iseas, Torben Frøstrup Hansen, Lars Henrik Jensen, Geerard Beets, Jean Pierre Gérard, Mireia Castillo-Martin, Nuno Figueiredo, Angelita Habr-Gama, Rodrigo Perez, Jérôme Galon, and Franck Pagès
5. Research Paper: Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
Authors: Rachael A. Clark, Jingbo Qiao, Jillian C. Jacobson, and Dai H. Chung
6. Research Paper: The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells
Authors: Austin McDermott, KyoungHyun Kim, Susan Kasper, Shuk-Mei Ho, and Yuet-Kin Leung
7. Research Paper: Early detection of treatment futility in patients with metastatic colorectal cancer
Authors: Jodi I. Rattner, Karen A. Kopciuk, Hans J. Vogel, Patricia A. Tang, Jeremy D. Shapiro, Dongsheng Tu, Derek J. Jonker, Lillian L. Siu, Chris J. O’Callaghan, and Oliver F. Bathe
8. Research Paper: Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype
Authors: Elham Khosrowabadi, Tomasz Wenta, Salla Keskitalo, Aki Manninen, and Sakari Kellokumpu
9. Editorial: Are 50 years enough to prove the brilliant Dilman’s idea?
Author: Vladimir N. Anisimov
10. Research Paper: GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
Authors: Laurence Booth, Cameron West, Robert P. Moore, Daniel Von Hoff, and Paul Dent
11. Research Paper: Exploiting protein family and protein network data to identify novel drug targets for bladder cancer
Authors: Tolulope Tosin Adeyelu, Aurelio A. Moya-Garcia, and Christine Orengo
12. Commentary: Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond
Author: Emil Lou
13. Research Paper: Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer
Authors: Ruiko Ogata, Shiori Mori, Hitoshi Ohmori, Shingo Kishi, Rina Fujiwara-Tani, Takamitsu Sasaki, Yukiko Nishiguchi, Chie Nakashima, Kei Goto, Isao Kawahara, Yi Luo, and Hiroki Kuniyasu
14. Research Paper: Chimeric chromosome landscapes of human somatic cell cultures show dependence on stress and regulation of genomic repeats by CGGBP1
Authors: Subhamoy Datta, Manthan Patel, Sukesh Kashyap, Divyesh Patel, and Umashankar Singh
15. Research Paper: Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol
Authors: Nkune Williams Nkune, Cherie Ann Kruger, and Heidi Abrahamse
16. Meeting Report: Seventh BHD international symposium: recent scientific and clinical advancement
Authors: Mark R. Woodford, Avgi Andreou, Masaya Baba, Irma van de Beek, Chiara Di Malta, Iris Glykofridis, Hannah Grimes, Elizabeth P. Henske, Othon Iliopoulos, Masatoshi Kurihara, Romain Lazor, W. Marston Linehan, Kenki Matsumoto, Stefan J. Marciniak, Yukiko Namba, Arnim Pause, Neil Rajan, Anindita Ray, Laura S. Schmidt, Wei Shi, Ortrud K. Steinlein, Julia Thierauf, Roberto Zoncu, Anna Webb, and Mehdi Mollapour
17. Research Paper: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications
Authors: Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Yuki Uchida, Ryoji Hyakudomi, Tetsu Yamamoto, Kiyoe Takai, Yohei Sasaki, Koki Kawakami, and Yoshitsugu Tajima
18. Research Paper: Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner
Authors: Sydney Weber Boutros, Destine Krenik, Sarah Holden, Vivek K. Unni, and Jacob Raber
19. Research Paper: Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Authors: Mauro Rogério de Barros Wanderley Jr., Mônica Samuel Ávila, Miguel Morita Fernandes-Silva, Fátima das Dores Cruz, Sara Michelly Gonçalves Brandão, Vagner Oliveira Carvalho Rigaud, Ludhmila Abrahão Hajjar, Roberto Kalil Filho, Edécio Cunha-Neto, Edimar Alcides Bocchi, and Silvia Moreira Ayub-Ferreira
20. Research Paper: Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer
Authors: Kanako Sendo, Manabu Seino, Tsuyoshi Ohta, and Satoru Nagase
21. Research Paper: Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
Authors: Ignacio Durán, Daniel Castellano, Javier Puente, Lidia Martín-Couce, Esther Bello, Urbano Anido, José Manuel Mas, and Luis Costa
22. Research Paper: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study
Authors: Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, and David Stenehjem
23. Research Paper: Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers
Authors: Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, and Massimo Cristofanilli
24. Research Paper: GZ17-6.02 and axitinib interact to kill renal carcinoma cells
Authors: Laurence Booth, Cameron West, Robert P. Moore, Daniel Von Hoff, and Paul Dent
25. Research Paper: PACER lncRNA regulates COX-2 expression in lung cancer cells
Authors: Samuel Z. Desind, Joseph R. Iacona, Christina Y. Yu, Antonina Mitrofanova, and Carol S. Lutz
26. Research Paper: Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature
Authors: Daniel de Castilho da Silva, Guilherme Di Camillo Orfali, Maycon Giovani Santana, Jessica Kaoru Yamamoto Palma, Isabella Ramos de Oliveira Assunção, Isadora Moraes Marchesi, Ana Yoshie Kitagawa Grizotto, Natália Peres Martinez, Simone Felliti, José Aires Pereira, and Denise Gonçalves Priolli
27. Research Paper: ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells
Authors: Benigno C. Valdez, David Murray, Bin Yuan, Yago Nieto, Uday Popat, and Borje S. Andersson
28. Research Paper: Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity
Authors: Daniel Menendez, Jay R. Anand, Carri C. Murphy, Whitney J. Bell, Jiaqi Fu, Nadia Slepushkina, Eugen Buehler, Scott E. Martin, Madhu Lal-Nag, John L. Nitiss, and Michael A. Resnick
29. Research Paper: Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker
Authors: Vincenz Sahm, Carlo Maurer, Theresa Baumeister, Akanksha Anand, Julia Strangmann, Roland M. Schmid, Timothy C. Wang, and Michael Quante
30. Research Paper: A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6
Authors: Truc T. Huynh, Sreeja Sreekumar, Cedric Mpoy, and Buck E. Rogers
31. Research Paper: NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model
Authors: Karen Cravero, Morgan V. Pantone, Dong Ho Shin, Riley Bergman, Rory Cochran, David Chu, Daniel J. Zabransky, Swathi Karthikeyan, Ian G. Waters, Natasha Hunter, D. Marc Rosen, Kelly Kyker-Snowman, W. Brian Dalton, Berry Button, Dan Shinn, Hong Yuen Wong, Joshua Donaldson, Paula J. Hurley, Sarah Croessmann, and Ben Ho Park
32. Research Paper: Metanephric adenoma: molecular study and review of the literature
Authors: Enrique Rodríguez-Zarco, Jesús Machuca-Aguado, Laura Macías-García, Ana Vallejo-Benítez, and Juan José Ríos-Martín
33. Review: The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
Authors: Alexander W. Pohlman, Hita Moudgalya, Lia Jordano, Gabriela C. Lobato, David Gerard, Michael J. Liptay, Christopher W. Seder, and Jeffrey A. Borgia
34. Review: The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
Authors: Ekaterina A. Lesovaya, Daria Chudakova, Gleb Baida, Ekaterina M. Zhidkova, Kirill I. Kirsanov, Marianna G. Yakubovskaya, and Irina V. Budunova
35. Research Paper: A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo
Authors: Mark H. Murdock, George S. Hussey, Jordan T. Chang, Ryan C. Hill, David G. Nascari, Aparna V. Rao, Kirk C. Hansen, Lesley M. Foley, T. Kevin Hitchens, Nduka M. Amankulor, and Stephen F. Badylak
36. Research Paper: Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
Authors: Somayeh Khazaei, Linn Nilsson, Gabriel Adrian, Helga Tryggvadottir, Elise Konradsson, Signe Borgquist, Karolin Isaksson, Crister Ceberg, and Helena Jernström
37. Commentary: Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
Author: Noel A. Warfel
Authors: Antonio Marchetti, Fiamma Buttitta and Emanuela D’Angelo
39. Research Paper: Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
Authors: Silvana Ebner, Ria Winkelmann, Saskia Martin, Jens Köllermann, Peter J. Wild, and Melanie Demes
40. Research Paper: An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid
Authors: Laura Moracci, Francesca Sensi, Andrea Biccari, Sara Crotti, Elisa Gaio, Federico Benetti, Pietro Traldi, Salvatore Pucciarelli, and Marco Agostini
41. Research Paper: Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Authors: Nancy Y. Villa, Masmudur M. Rahman, Joseph Mamola, Meaghen E. Sharik, Ana Lemos de Matos, Jacquelyn Kilbourne, Kenneth Lowe, Juliane Daggett-Vondras, Julia D'Isabella, Elizabeth Goras, Marta Chesi, P. Leif Bergsagel, and Grant McFadden
42. Research Paper: Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Authors: Ludmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, Jeanne-Marie Berner, Bodil Bjerkehagen, Ivar Hompland, Ingvild Lobmaier, Toto Hølmebakk, Tarjei S. Hveem, Sverre Heim, and Francesca Micci
43. Research Paper: Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
Authors: Eric R. Molina, Letitia K. Chim, Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, David McCall, Branko Cuglievan, Sandhya Krishnan, Robert W. Porter, Davis R. Ingram, Wei-Lien Wang, Alexander J. Lazar, David W. Scott, Danh D. Truong, Najat C. Daw, Joseph A. Ludwig, and Antonios G. Mikos
44. Research Paper: MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis
Authors: Pratima Nangia-Makker, Malathy P.V. Shekhar, Victor Hogan, Vitaly Balan, and Avraham Raz
Authors: Magdalena Cybula and Magdalena Bieniasz
46. Case Report: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
Authors: Eugene J. Vaios, Kristen A. Batich, Anne F. Buckley, Anastasie Dunn-Pirio, Mallika P. Patel, John P. Kirkpatrick, Ranjit Goudar, and Katherine B. Peters
47. Research Paper: Role of the prorenin receptor in endometrial cancer cell growth
Authors: Jacinta H. Martin, Riazuddin Mohammed, Sarah J. Delforce, David A. Skerrett-Byrne, Celine Corbisier de Meaultsart, Juhura G. Almazi, Andrew N. Stephens, Nicole M. Verrills, Evdokia Dimitriadis, Yu Wang, Eugenie R. Lumbers, and Kirsty G. Pringle
48. Research Paper: A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis
Authors: Arvand Asghari, Katherine Wall, Michael Gill, Natascha Del Vecchio, Farnaz Allahbakhsh, Jacky Wu, Nan Deng, W. Jim Zheng, Hulin Wu, Michihisa Umetani, and Vahed Maroufy
49. Research Paper: Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis
Authors: Jessica I. Christian, Agnieszka Pastula, Andreas Herbst, Jens Neumann, Maximilian K. Marschall, Andrea Ofner, Heike Zierahn, Marlon R. Schneider, Eckhard Wolf, Michael Quante, and Frank T. Kolligs
50. Research Paper: Bladder cancer survival in patients with NOD2 or CDKN2A variants
Authors: Elżbieta Złowocka-Perłowska, Thierry van de Wetering, Aleksandra Tołoczko-Grabarek, Rodney J. Scott, and Jan Lubiński
51. Research Paper: Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells
Authors: Laura Valdez, Benxu Cheng, Daniela Gonzalez, Reanna Rodriguez, Paola Campano, Andrew Tsin, and Xiaoqian Fang
52. Research Paper: Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
Authors: Malalage N. Peiris, April N. Meyer, Dalida Warda, Alexandre Rosa Campos, and Daniel J. Donoghue
53. Research Paper: Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score–matched analysis of E7438-G000-101 trial outcomes
Authors: David G. Proudman, Deepshekhar Gupta, Dave Nellesen, Jay Yang, Beth A. Kamp, Khalid Mamlouk, and Bruce D. Cheson
54. Research Paper: Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study
Authors: Carolina Sciortino, Valentina Viglialoro, Massimo Nucci, Mariam Grazia Polito, Enrico Cortesi, Alain Gelibter, Paola Gazzaniga, Chiara Nicolazzo, Marco Siringo, and Salvatore Caponnetto
55. Research Paper: CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling
Authors: Limeng Pu, Manali Singha, Jagannathan Ramanujam, and Michal Brylinski
56. Research Paper: NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer
Authors: Travis P. Schrank, Andrew C. Prince, Tejas Sathe, Xiaowei Wang, Xinyi Liu, Damir T. Alzhanov, Barbara Burtness, Albert S. Baldwin, Wendell G. Yarbrough, and Natalia Issaeva
57. Research Paper: Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach
Authors: Pooja Gulhane, Prajakta Nimsarkar, Komal Kharat, and Shailza Singh
58. Research Paper: HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer
Authors: Naokazu Chiba, Shigeto Ochiai, Takahiro Gunji, Toshimichi Kobayashi, Toru Sano, Koichi Tomita, and Shigeyuki Kawachi
59. Research Paper: Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes
Authors: Olga Y. Gorlova, Marek Kimmel, Spiridon Tsavachidis, Christopher I. Amos, and Ivan P. Gorlov
60. Review: Targeting lipid metabolism in the treatment of ovarian cancer
Authors: Saliha Chaudhry, Stefani N. Thomas, and Glenn E. Simmons Jr.
61. Research Paper: IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells
Authors: Chau P. Tran, Michelle Scurr, Louise O’Connor, Jon N. Buzzelli, Garrett Z. Ng, Sharleen Chung Nien Chin, Lincon A. Stamp, Toshinari Minamoto, Andrew S. Giraud, Louise M. Judd, Philip Sutton, and Trevelyan R. Menheniott
Authors: Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, and Patrick Pauwels
63. Research Paper: Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program
Authors: Reyes Bernabé-Caro, Pilar Garrido, Rosario García-Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, Delvys Rodríguez-Abreu, Marta López-Brea, Alfredo Paredes, David Vicente, José Miguel Sánchez Torres, Margarita Majem, Pilar Diz, Rocío Gordo, Margarita Coca, and Javier de Castro
64. Review: Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
Authors: Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, Daniel Antwi-Amoabeng, Ganiyu A. Rahman, and Olatunji B. Alese
Visit www.Oncotarget.com to read the latest publications in Volume 13.
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
- Twitter – https://twitter.com/Oncotarget
- Facebook – https://www.facebook.com/Oncotarget
- YouTube – www.youtube.com/c/OncotargetYouTube
- Instagram – https://www.instagram.com/oncotargetjrnl/
- LinkedIn – https://www.linkedin.com/company/oncotarget/
- Pinterest – https://www.pinterest.com/oncotarget/
- LabTube – https://www.labtube.tv/channel/MTY5OA
- SoundCloud – https://soundcloud.com/oncotarget
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
Journal
Oncotarget